The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Volkova E.N.

N.I. Pirogov Russian State Medical University

Esimbieva M.L.

State Educational Institution of higher professional education "N.I. Pirogov Russian State Medical University", Russian Ministry of Health and Social Development, Moscow

Landysheva K.A.

State Educational Institution of higher professional education "N.I. Pirogov Russian State Medical University", Russian Ministry of Health and Social Development, Moscow

Lebedeva S.V.

Central Military Clinical Hospital, Ministry of Defense of the Russian Federation, Moscow

Elistratova I.V.

State institution "Central Military Clinical Hospital of Internal Military Forces", Russian Ministry of Internal Affairs, Balashikha, Moscow region

The innovative treatment of patients with acne: preliminary results of therapy

Authors:

Volkova E.N., Esimbieva M.L., Landysheva K.A., Lebedeva S.V., Elistratova I.V.

More about the authors

Read: 2741 times


To cite this article:

Volkova EN, Esimbieva ML, Landysheva KA, Lebedeva SV, Elistratova IV. The innovative treatment of patients with acne: preliminary results of therapy. Russian Journal of Clinical Dermatology and Venereology. 2011;9(1):59‑63. (In Russ.)

Recommended articles:
Historical aspe­cts and prospects of psoriasis treatment. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):284-292
Study of the role of inte­rleukin-1β in blood serum in patients with acne. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):421-424
Adhe­rence of patients to acne therapy using systemic isotretinoin. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):483-488
Clinical discussion of patients with follicular occlusion syndrome and como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):596-603
Rational choice of combined therapy of acne: systemic isotretinoin and high-energy hardware technologies. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):651-656

References:

  1. Gollnick H., Cunliffe W., Berson D. et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003;49:S1-S37.
  2. Hoeffler U. Enzymatic and hemolytic properties of Propionibacterium acnes and related bacteria. J Clin Microbiol 1977;6:555-558.
  3. Jeremy A.H., Holland D.B., Roberts S.G. et al. Inflammatory events are involved in acne lesion initiation. J Inv Dermatol 2003;121:21-27.
  4. Plewig G., Kligman A. Acne & rosacea, 3rd ed. Berlin: Springer 2002.
  5. Yoshimoto T., Takeda K., Tanaka T. et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergismwith IL-18 for IFN-gammaproduction. J Immunol 1998;161:3400-3407.
  6. Jung Y.S., Matsumoto S.E., Yamashita M. et al. Propionibacterium Acnes acts as an adjuvant in in vitro immunization of human peripheral blood mononuclear cells. Biosci Biotechnol Biochem 2007;71:1963-1969.
  7. Kim J., Ochoa M.T., Krutzik S.R. et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002;169:1535-1541.
  8. Mouser P.E., Baker B.S., Seaton E.D., Chu A.C. Propionibacterium acnes-reactive T helper-1 cells in the skin of patients with acne vulgaris. J Inv Dermatol 2003;121:1226-1228.
  9. Zouboulis C.C., Eady A., Philpott M. et al. What is the pathogenesis of acne? Exp Dermatol 2005;14:143-152.
  10. Guy R., Kealey T. Modelling the infundibulum in acne. Dermatology 1998;196:32-37.
  11. Kim J. Review of the innate immune response in acne vulgaris: activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatol 2005;211:193-198.
  12. Kuwahara K., Kitazawa T., Kitagaki H. et al. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes. J Dermatol Sci 2005;38:47-55.
  13. Kloppenburg M., Verweij C.L., Miltenburg A.M. et al. The influence of tetracyclines on T cell activation. Clin Exp Immunol 1995;102:635-641.
  14. Kurokawa I., Mayer-da-Silva A., Gollnick H., Orfanos C.E. Monoclonal antibody labeling for cytokeratins and filaggrin in the human pilosebaceous unit of normal, seborrhoeic and acne skin. J Inv Dermatol 1988;91:566-571.
  15. Layton A.M., Morris C., Cunliffe W.J., Ingham E. Immunohistochemical investigation of evolving inflammation in lesions of acne vulgaris. Exp Dermatol 1998;7:191-197.
  16. Leyden J.J. Med Therapy for acne vulgaris. N Engl J Med 1997;336:1156-1162.
  17. Thiboutot D.M., Knaggs H., Gilliland K., Hagari S. Activity of type 1,5 Alphareductase is greater in the follicular infrainfundibulum compared with the epidermis. Br J Dermatol 1997;136:166-171.
  18. Tsutsui H., Yoshimoto T., Hayashi N. et al. Induction of allergic inflammation by interleukin-18 in experimental animal models. Immunol Rev 2004;202:115-138.
  19. Yamanaka K., Tanaka M., Tsutsui H. et al. Skinspecific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. J Immunol 2000;165:997-1003.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.